High Lipoprotein(a) Level Is Independently Associated with Adverse Clinicopathological Features in Patients with Prostate Cancer

Table 2

Lipid parameters of the study population stratified by PSA values.

	PSA values
	()	()	value
Demographic characteristics
Age (years)			0.071
BMI (kg/m^2)			0.001
Hypertension ( (%))	85 (38.6)	54 (34.6)	0.448
Diabetes mellitus ( (%))	31 (14.1)	18 (11.5)	0.535
Coronary artery disease ( (%))	39 (17.7)	17 (10.9)	0.078
Lipid-lowering drugs ( (%))	7 (3.2)	2 (1.3)	0.315
Lipid parameters
TG (mmol/l)	1.04 (0.73-1.39)	1.05 (0.78-1.39)	0.888
TC (mmol/l)			0.180
LDL-C (mmol/l)			0.140
HDL-C (mmol/l)			0.099
TC/HDL-C			0.764
LDL-C/HDL-C			0.919
RC (mmol/l)			0.279
Lp(a) (mg/l)	188 (90-359)	253.0 (139.3-445.8)	0.002

Data are expressed as (%), , or median (25th-75th percentile). The bold value indicated statistical significance. PCa = prostate cancer; BMI = body mass index; PSA = prostate-specific antigen; RC = remnant cholesterol; TC = total cholesterol; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; TG = triglycerides; Lp(a) = lipoprotein(a).